MNMD – mind medicine (mindmed) inc. - common shares (US:NASDAQ)
Stock Stats
News
MindMed Announces New Employee Inducement Grants
MindMed Appoints Matt Wiley as Chief Commercial Officer
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its price target lowered by analysts at Robert W. Baird from $27.00 to $16.00. They now have an "outperform" rating on the stock.
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates
Form 4 Mind Medicine (MindMed) For: Mar 25 Filed by: Karlin Daniel
Form 4 Mind Medicine (MindMed) For: Mar 25 Filed by: Sullivan Mark
Form 4 Mind Medicine (MindMed) For: Mar 25 Filed by: Liao Carrie
Form 4 Mind Medicine (MindMed) For: Mar 25 Filed by: Barrow Robert
Form 144 Mind Medicine (MindMed) Filed by: Sullivan Mark
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.